BUPRENORPHIN ENTHALTENDE ZUBEREITUNG

Patent europeic · EP1499360 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1499360
Numer da la dumonda
EP03712380
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
19-03-2003
Publitgà
26-01-2005
Concedì
08-10-2008
Stritgà
31-03-2015
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 47/36 (2006.01)
A61K 31/485 (2006.01)
A61K 9/08 (2006.01)
Prioritad
GB 0206448 19.03.2002
GB 0225040 28.10.2002
GB 0225041 28.10.2002
GB 0225042 28.10.2002
Dumonda PCT
PCT/GB2003/001183 19.03.2003
Publicaziun PCT
WO2003/080021 02.10.2003
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 21-10-2015

    Stritgà, taxa betg pajada

    Published in Swissreg on 21.10.2015

  2. 18-02-2009

    Represchentant inscrit

    Representative
    Patentanwälte, Schaad, Balass, Menzl & Partner AG, Dufourstrasse 101, 8034 Zürich

    Published in Swissreg on 18.02.2009

  3. 08-10-2008

    Concedì

    Published in Swissreg on 08.10.2008

Partidas

Possessur

Vernalis (R&D) Limited

Oakdene Court 613 Reading Road, Winnersh Berkshire RG14 5UA, GB

Archimedes Development Limited

Albert Einstein Centre, Nottingham Science & Technology Park, University Boulevard, Nottingham NG7 2TN, GB

Represchentant

Patentanwälte Schaad, Balass, Menzl & Partner AG

Dufourstrasse 101, 8034 Zürich

Inventur

BIRCH, Phillip John

Cambridge CB4 0PA, GB

HAYES, Ann Gail

Cambridge CB4 0PA, GB

WATTS, Peter James, Albert Einstein Centre

Nottingham NG7 2TN, GB

CASTILE, Jonathan David, Albert Einstein Centre

Nottingham NG7 2TN, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.